Clinical Trials Browser

Observation × Gastrointestinal × 1 year × Clear all

NCT03233711 2026-03-18

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Phase 3 Active not recruiting

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT06896370 2026-02-25

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

Gastrointestinal

Stomach Neoplasms, Helicobacter Infections

NCT06192719 2026-02-18

EULAT

15,000 enrolled

Gastrointestinal

Cholelithiasis, Gallbladder Neoplasms

NCT07405476 2026-02-12

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT07400354 2026-02-10

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Gastrointestinal

Stomach Neoplasms

NCT07177742 2026-02-06

Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis

Gastrointestinal

Colorectal Neoplasms

NCT07391007 2026-02-05

Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases

Not yet recruiting

Gastrointestinal

Colorectal Liver Metastases

NCT06958328 2026-02-02

LAP100

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Phase 3 Active not recruiting

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

NCT07250100 2025-11-26

MICROPAC

Gastrointestinal

Pancreatic Neoplasms

NCT03594630 2025-11-06

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT04120935 2025-08-24

ALFAOMEGA

Gastrointestinal

Colorectal Neoplasms

NCT05101382 2025-08-24

ALFAOMEGA-R

Gastrointestinal

Gastrointestinal Diseases, Colorectal Neoplasms

NCT03602092 2025-05-22

Observational Registry Data on GIST Patients

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Phase 2/3 Active not recruiting

635 enrolled 9 charts

Gastrointestinal

Colonic Neoplasms

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05234177 2025-05-06

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT06933966 2025-04-18

ATTENUATION

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms